Quick Summary:
In the expanding healthcare landscape, the Global Bloodstream Infection Testing Market offers promising investment potential, currently estimated at US$10 Billion and projected to surge to US$17.1 Billion by 2030. This rapid expansion model reflects the ascendant importance of swift and precise diagnosis in the medical field, as well as the continual refinement of associated technologies in this vital area of medical science.
Our comprehensive report provides a detailed image of not only the projected growth, but also the competitive landscape involving leading players like Abbott Laboratories, Danaher Corporation and Thermo Fisher Scientific, Inc. Gain a competitive edge with access to key market shares, market presence across numerous geographies, and dynamic peer-to-peer collaborative bespoke updates. With additional perks such as access to extensive digital archives and complimentary updates for the next 12 months, investing in this report affords an unparalleled advantage in strategic planning and data-driven decision making.
Global Bloodstream Infection Testing Market to Reach $17.1 Billion by 2030
The global market for Bloodstream Infection Testing estimated at US$10 Billion in the year 2022, is projected to reach a revised size of US$17.1 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2022-2030. Conventional Testing, one of the segments analyzed in the report, is projected to record 7.7% CAGR and reach US$12.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Non-Conventional Testing segment is readjusted to a revised 5% CAGR for the next 8-year period.The U.S. Market is Estimated at $2.7 Billion, While China is Forecast to Grow at 10.5% CAGR
The Bloodstream Infection Testing market in the U.S. is estimated at US$2.7 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$4.2 Billion by the year 2030 trailing a CAGR of 10.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.5% and 6.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.Select Competitors (Total 42 Featured) -
- Abbott Laboratories
- Becton, Dickinson & Company
- bioMerieux SA
- Danaher Corporation
- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Bloodstream Infection Testing?
What is the growth rate of the Global Market for Bloodstream Infection Testing?
What is the forecasted size of the Global Market for Bloodstream Infection Testing?
Who are the key companies in the Global Market for Bloodstream Infection Testing?
Report Attribute | Details |
---|---|
No. of Pages | 173 |
Published | October 2023 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 10 Billion |
Forecasted Market Value ( USD | $ 17.1 Billion |
Compound Annual Growth Rate | 6.9% |
Regions Covered | Global |
Table of Contents
- Influencer Market Insights
- World Market Trajectories
- Bloodstream Infection Testing - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
- Table 1: World Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 2: World Historic Review for Bloodstream Infection Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 3: World 16-Year Perspective for Bloodstream Infection Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
- Table 4: World Recent Past, Current & Future Analysis for Conventional Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 5: World Historic Review for Conventional Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 6: World 16-Year Perspective for Conventional Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Non-Conventional Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 8: World Historic Review for Non-Conventional Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 9: World 16-Year Perspective for Non-Conventional Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 10: World Bloodstream Infection Testing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
- Bloodstream Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- Table 11: USA Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 12: USA Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 13: USA 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Table 14: Canada Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 15: Canada Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 16: Canada 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Bloodstream Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- Table 17: Japan Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 18: Japan Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 19: Japan 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Bloodstream Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- Table 20: China Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 21: China Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 22: China 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Bloodstream Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- Table 23: Europe Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 24: Europe Historic Review for Bloodstream Infection Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 25: Europe 16-Year Perspective for Bloodstream Infection Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
- Table 26: Europe Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 27: Europe Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 28: Europe 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Bloodstream Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- Table 29: France Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 30: France Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 31: France 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Bloodstream Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- Table 32: Germany Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 33: Germany Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 34: Germany 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Table 35: Italy Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 36: Italy Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 37: Italy 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Bloodstream Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- Table 38: UK Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 39: UK Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 40: UK 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Table 41: Spain Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 42: Spain Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 43: Spain 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Table 44: Russia Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 45: Russia Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 46: Russia 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Table 47: Rest of Europe Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 48: Rest of Europe Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 49: Rest of Europe 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Bloodstream Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- Table 50: Asia-Pacific Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 51: Asia-Pacific Historic Review for Bloodstream Infection Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 52: Asia-Pacific 16-Year Perspective for Bloodstream Infection Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
- Table 53: Asia-Pacific Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 54: Asia-Pacific Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 55: Asia-Pacific 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Bloodstream Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
- Table 56: Australia Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 57: Australia Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 58: Australia 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Bloodstream Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
- Table 59: India Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 60: India Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 61: India 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Table 62: South Korea Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 63: South Korea Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 64: South Korea 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Table 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 66: Rest of Asia-Pacific Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 67: Rest of Asia-Pacific 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Bloodstream Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
- Table 68: Latin America Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 69: Latin America Historic Review for Bloodstream Infection Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 70: Latin America 16-Year Perspective for Bloodstream Infection Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
- Table 71: Latin America Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 72: Latin America Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 73: Latin America 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Table 74: Argentina Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 75: Argentina Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 76: Argentina 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Table 77: Brazil Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 78: Brazil Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 79: Brazil 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Table 80: Mexico Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 81: Mexico Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 82: Mexico 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Table 83: Rest of Latin America Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 84: Rest of Latin America Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 85: Rest of Latin America 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Bloodstream Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
- Table 86: Middle East Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 87: Middle East Historic Review for Bloodstream Infection Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 88: Middle East 16-Year Perspective for Bloodstream Infection Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
- Table 89: Middle East Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 90: Middle East Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 91: Middle East 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Table 92: Iran Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 93: Iran Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 94: Iran 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Table 95: Israel Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 96: Israel Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 97: Israel 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Table 98: Saudi Arabia Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 99: Saudi Arabia Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 100: Saudi Arabia 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Table 101: UAE Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 102: UAE Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 103: UAE 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Table 104: Rest of Middle East Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 105: Rest of Middle East Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 106: Rest of Middle East 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
- Bloodstream Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
- Table 107: Africa Recent Past, Current & Future Analysis for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 108: Africa Historic Review for Bloodstream Infection Testing by Technology - Conventional Testing and Non-Conventional Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 109: Africa 16-Year Perspective for Bloodstream Infection Testing by Technology - Percentage Breakdown of Value Sales for Conventional Testing and Non-Conventional Testing for the Years 2014, 2023 & 2030
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott Laboratories
- Becton, Dickinson & Company
- bioMerieux SA
- Danaher Corporation
- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific, Inc.